Editors' Pick Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM Lancet Neurol. 2013 Apr 25. Epub 1969 Dec 31. PMID: 23623397. Abstract CommentRecommendBookmarkWatch